
"I am glad that taking part in a trial might help others on their own cancer journey.”
This study is in 2 parts.
Part 1
The first part of the study was a feasibility study to check the trial was possible. Part 1 has successfully completed.
People who participated in part 1 might still be able to take part in part 2.
Part 2
The second part of this study will recruit more than 400 patients. This part of the study is running for 3 years.
The aim of this part of the study is to match each patient to a phase 1 trial, based on the alterations in their DNA.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Matthew Krebs
Cancer Research UK Manchester Institute
Experimental Cancer Medicine Centre (ECMC)
Manchester Centre for Genomic Medicine
Manchester Cancer Research Centre (MCRC)
The Christie NHS Foundation trust
Freephone 0808 800 4040
"I am glad that taking part in a trial might help others on their own cancer journey.”